Economic Evaluation of 5-Grass Pollen Tablets Versus Placebo in the Treatment of Allergic Rhinitis in Adults

被引：0
|
作者：
Matteo Ruggeri
Marco Oradei
Franco Frati
Paola Puccinelli
Cristina Romao
Ilaria Dell’Albani
Cristoforo Incorvaia
Americo Cicchetti
机构：
[1] Università Cattolica del Sacro Cuore,Faculty of Economics
[2] Policlinico Universitario A. Gemelli,Technology Evaluation Unit
[3] Stallergenes,Medical and Scientific Department
[4] Stallergenes SA,Market Access Department
[5] ICP Hospital,Allergy/Pulmonary Rehabilitation
来源：
Clinical Drug Investigation | 2013年 / 33卷
关键词：
Allergic Rhinitis; Allergic Rhinitis; Probabilistic Sensitivity Analysis; Discrimination Threshold; Allergic Rhinitis Patient;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：343 / 349
页数：6
相关论文
共 50 条
  • [21] SAFETY OF 300IR 5-GRASS POLLEN SUBLINGUAL TABLET FOR THE TREATMENT OF GRASS POLLEN-INDUCED ALLERGIC RHINOCONJUNCTIVITIS IN ADULTS AND PEDIATRIC SUBJECTS WITH INTERMITTENT ASTHMA
    Parkes, Alicia
    Cognet-Sice, Josiane
    Abiteboul, Kathy
    INTERNAL MEDICINE JOURNAL, 2016, 46 : 20 - 20
  • [22] A Us Study Of 5-grass Pollen Allergen Extract In Adults With Grass Pollen-induced Allergic Rhinoconjunctivitis - Results Of Secondary Efficacy Assessments
    Cox, L.
    Casale, T. B.
    Nayak, A.
    Creticos, P.
    Montagut, A.
    Zeldin, R. K.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB46 - AB46
  • [23] Long-term clinical efficacy of a 5-grass pollen sublingual immunotherapy tablet in adults with grass pollen-induced allergic rhinoconjunctivitis
    Didier, A.
    Horak, F.
    Worm, M.
    Melac, M.
    de Beaumont, O.
    Montagut, A.
    Galvain, S.
    Rodriguez, P.
    Malling, H.
    ALLERGY, 2011, 66 : 654 - 654
  • [24] Comparison of the effect of 5-grass pollen sublingual immunotherapy tablets and drops in children with rhinoconjunctivitis
    Jerzynska, Joanna
    Stelmach, Wlodzimierz
    Majak, Pawel
    Stelmach, Rafal
    Janas, Anna
    Stelmach, Iwona
    ALLERGY AND ASTHMA PROCEEDINGS, 2018, 39 (01) : 66 - 73
  • [25] Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis
    Didier, Alain
    Malling, Hans-Jorgen
    Worm, Margitta
    Horak, Friedrich
    Jaeger, Siegfried
    Montagut, Armelle
    Andre, Claude
    de Beaumont, Olivier
    Melac, Michel
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 120 (06) : 1338 - 1345
  • [26] Relationship between allergic disease severity and efficacy of 300IR 5-grass pollen SLIT tablets for sublingual immunotherapy
    Didier, A.
    Horak, F.
    Worm, M.
    Melac, M.
    de Beaumont, O.
    Le Gall, M.
    Montagut, A.
    Rodriguez, P.
    Malling, A.
    ALLERGY, 2011, 66 : 137 - 138
  • [27] 300IR 5-Grass pollen sublingual tablet offers relief from nasal symptoms in patients with allergic rhinitis
    Serrano, Elie
    Wahn, Hans Ulrich
    Didier, Alain
    Bachert, Claus
    AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2014, 28 (06) : 471 - 476
  • [28] Treating grass pollen allergic patients with severe allergic rhinoconjunctivitis symptoms with 5-grass pollen tablets results from a 2-year real-life medical practice study
    Karagiannis, E.
    Hadler, M.
    Shah-Hosseini, K.
    Moesges, R.
    ALLERGY, 2014, 69 : 413 - 413
  • [29] Clinical profile of patients with grass pollen allergic rhinoconjunctivitis in a study of 300 IR 5-grass pollen sublingual tablet
    Didier, A.
    Malling, H.
    Worm, M.
    Cadic, V
    Lheritier-Barrand, M.
    Zeldin, R.
    ALLERGY, 2012, 67 : 409 - 409
  • [30] Update about Oralair® as a treatment for grass pollen allergic rhinitis
    Klimek, L.
    Brehler, R.
    Moesges, R.
    Demoly, P.
    Mullol, J.
    Wang, D. Y.
    O'Hehir, R. E.
    Didier, A.
    Kopp, M.
    Bos, C.
    Karagiannis, E.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)
12345